| COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection H Al-Samkari, RS Karp Leaf, WH Dzik, JCT Carlson, AE Fogerty, ... Blood, The Journal of the American Society of Hematology 136 (4), 489-500, 2020 | 1476 | 2020 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ... MedRxiv, 2021.01. 07.21249390, 2021 | 1455 | 2021 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1144 | 2021 |
| Factors associated with death in critically ill patients with coronavirus disease 2019 in the US S Gupta, SS Hayek, W Wang, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 180 (11), 1436-1447, 2020 | 1027 | 2020 |
| Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors FB Cortazar, KA Marrone, ML Troxell, KM Ralto, MP Hoenig, JR Brahmer, ... Kidney International 90 (3), 638-647, 2016 | 651 | 2016 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 631 | 2021 |
| Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19 S Gupta, W Wang, SS Hayek, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 181 (1), 41-51, 2021 | 572 | 2021 |
| Target trial emulation: a framework for causal inference from observational data MA Hernán, W Wang, DE Leaf Jama 328 (24), 2446-2447, 2022 | 382 | 2022 |
| Clinical features and outcomes of immune checkpoint inhibitor–associated AKI: a multicenter study FB Cortazar, ZA Kibbelaar, IG Glezerman, A Abudayyeh, O Mamlouk, ... Journal of the American Society of Nephrology 31 (2), 435-446, 2020 | 343 | 2020 |
| AKI treated with renal replacement therapy in critically ill patients with COVID-19 S Gupta, SG Coca, L Chan, ML Melamed, SK Brenner, SS Hayek, ... Journal of the American Society of Nephrology 32 (1), 161-176, 2021 | 334 | 2021 |
| De novo NAD+ biosynthetic impairment in acute kidney injury in humans A Poyan Mehr, MT Tran, KM Ralto, DE Leaf, V Washco, J Messmer, ... Nature medicine 24 (9), 1351-1359, 2018 | 334 | 2018 |
| Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness DE Leaf, DS Goldfarb Journal of applied physiology, 2007 | 289 | 2007 |
| Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States JE Flythe, MM Assimon, MJ Tugman, EH Chang, S Gupta, J Shah, ... American Journal of Kidney Diseases 77 (2), 190-203. e1, 2021 | 269 | 2021 |
| The incidence, causes, and risk factors of acute kidney injury in patients receiving immune checkpoint inhibitors H Seethapathy, S Zhao, DF Chute, L Zubiri, Y Oppong, I Strohbehn, ... Clinical Journal of the American Society of Nephrology 14 (12), 1692-1700, 2019 | 257 | 2019 |
| Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19 S Shaefi, SK Brenner, S Gupta, BP O’Gara, ML Krajewski, DM Charytan, ... Intensive care medicine 47, 208-221, 2021 | 216 | 2021 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 209 | 2021 |
| Plasma FGF23 levels increase rapidly after acute kidney injury M Christov, SS Waikar, RC Pereira, A Havasi, DE Leaf, D Goltzman, ... Kidney International 84 (4), 776-785, 2013 | 202 | 2013 |
| Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia DE Leaf, DS Goldfarb Kidney international 75 (1), 15-24, 2009 | 198 | 2009 |
| Soluble urokinase receptor and acute kidney injury SS Hayek, DE Leaf, A Samman Tahhan, M Raad, S Sharma, SS Waikar, ... New England Journal of Medicine 382 (5), 416-426, 2020 | 197 | 2020 |
| Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference JL Babitt, MF Eisenga, VH Haase, AV Kshirsagar, A Levin, F Locatelli, ... Kidney international 99 (6), 1280-1295, 2021 | 184 | 2021 |